Oral contraceptives and thrombosis: An overview of study methods and recent results

American Journal of Obstetrics and Gynecology

Volumn 179, Issue 3 II, 1998, Pages

  Westhoff, C L ^a  

^a NONE   (United States)

Author keywords

Methodology; Oral contraceptives; Thrombosis

Indexed keywords

ESTROGEN; GESTAGEN;

DOSE RESPONSE; DRUG FORMULATION; DRUG SAFETY; FEMALE; HORMONAL CONTRACEPTION; HUMAN; ORAL CONTRACEPTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; THROMBOSIS;

EID: 0031670783     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1053/ob.1998.v179.a91673     Document Type: Article

References (18)

1. J Realini J. Goldzieher Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies Am J Obstet Gynecol 152 1985 729 798
2. M Vessey D Mant A Smith D. Yeates Oral contraceptives and venous thromboembolism: findings in a large prospective study BMJ (Clin Res Ed) 292 1986 526
3. Royal College of General Practitioners. Oral contraceptives, venous thrombosis and varicose veins J R Coll Gen Pract 28 1978 393 399
4. PD Stolley JA Tonascia MS Tockman PE Sartwell AH Rutledge MP. Jacobs Thrombosis with low-estrogen oral contraceptives Am J Epidemiol 102 1975 197 208
5. TW Meade G Greenberg SG. Thompson Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations BMJ 280 1980 1157 1161
6. O. Lidegaard Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study BMJ 306 1993 956 963
7. BB Gerstmann JM Piper DK Tomita WJ Ferguson BV Stadel FE. Lundin Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease Am J Epidemiol 133 1991 32 37
8. World Health Organization Collaborative Study of Cardiovascular Disease Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of an international multicentre case-control study Lancet 346 1995 1575 1582
9. World Health Organization Collaborative Study of Cardiovascular Disease Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease Lancet 346 1995 1582 1588
10. H Jick SS Jick V Gurewich MW Myers C. Vasilikis Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components Lancet 346 1995 1589 1593
11. WO Spitzer MA Lewis LA Heinemann M Thorogood KD. MacRae Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women BMJ 312 1996 83 88
12. US Preventive Services Task Force. Guide to clinical preventive services 2nd ed 1996 International Medical Publishing Alexandria (VA)
13. RD Farmer TD. Preston The risk of venous thromboembolism associated with low oestrogen oral contraceptives J Obstet Gynecol 15 1995 195 200
14. RD Farmer RA Lawrenson CR Thompson JG Kennedy IR. Hambleton Population-based study of risk of venous thromboembolism associated with various oral contraceptives Lancet 349 1997 83 88
15. JP Vandenbroucke T Koster E Brieet PH Reitsma RM Bertina FR. Rosendaal Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation Lancet 344 1994 1453 1457
16. O Lidegaard I. Milson Oral contraceptives and thrombotic diseases: impact of new epidemiological studies Contraception 53 1996 135 139
17. TM Farley O. Meirik Oral contraceptives and thrombotic diseases: impact of new epidemiological studies Contraception 54 1996 193 195 [letter]
18. S Suissa L Blais W Spitzer J Cusson M Lewis L. Heinemann First-time use of newer oral contraceptives and the risk of venous thromboembolism Contraception 56 1997 141 146